Journal of Virus Eradication (Dec 2017)
HIV-DNA, CD32a CD4+ T-cells and immune activation on successfull dolutegravir-based regimen
- P. Gantner,
- M. Partisani,
- C. Barnig,
- G. Beck-Wirth,
- J.P. Faller,
- M. Artinot,
- M. Mohseni-Zadeh,
- C. Cheneau,
- M.L. Batard,
- A. Fuchs,
- P. Fischer,
- S. Bahram,
- D. Rey,
- S. Fafi-Kremer
Affiliations
- P. Gantner
- Strasbourg University, INSERM, UMR-S 1109, Strasbourg, France
- M. Partisani
- Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France
- C. Barnig
- Physiology and functional explorations department, Strasbourg University Hospital, Strasbourg, France
- G. Beck-Wirth
- Internal Medicine Department, HIV-infection care center, Groupe Hospitalier Regional-Mulhouse Sud Alsace, Mulhouse, France
- J.P. Faller
- Department of Infectious Diseases, Hôpital Nord Franche Comté, Belfort, France
- M. Artinot
- Internal Medicine and Rheumatology Department, Hôpital Civil de Colmar, Colmar, France
- M. Mohseni-Zadeh
- Internal Medicine and Rheumatology Department, Hôpital Civil de Colmar, Colmar, France
- C. Cheneau
- Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France
- M.L. Batard
- Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France
- A. Fuchs
- Virology laboratory, Strasbourg University Hospital, Strasbourg, France
- P. Fischer
- Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France
- S. Bahram
- Strasbourg University, INSERM, UMR-S 1109, Strasbourg, France
- D. Rey
- Le Trait d'Union, HIV-infection care center, Strasbourg University Hospital, Strasbourg, France
- S. Fafi-Kremer
- Virology laboratory, Strasbourg University Hospital, Strasbourg, France; Strasbourg University, INSERM, UMR-S 1109, Strasbourg, France
- Journal volume & issue
-
Vol. 3
p. 30